OLN Stock Recent News

London, U.K., January 27 2025, Swarm Oncology Ltd. (“Swarm Oncology” or “the Company”), a biotechnology company pioneering novel T cell therapies to achieve long-term remission in patients with advanced solid cancers, today emerges from stealth mode and announces the appointment of Martin Olin as Chief Executive Officer.

Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OLN is set to acquire AMMO's small caliber ammunition manufacturing assets for $75 million to enhance participation across high-margin specialty calibers.

Leverages Winchester's integration across commercial ammunition value chain Enhances our ability to participate across high-margin specialty calibers Drives value creation through immediate adjusted EBITDA accretion and a fully realized expected synergy benefit of $40 million CLAYTON, Mo., Jan. 21, 2025 /PRNewswire/ -- Olin Corporation (NYSE: OLN) ('Olin') today announced it has entered into a definitive agreement with AMMO, Inc. (NASDAQ: POWW) ('AMMO') whereby Olin will acquire AMMO's small caliber ammunition manufacturing assets for a purchase price of $75 million.

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO,” “we,” “us,” “our” or the “Company”), the owner of GunBroker.com, the largest online marketplace for firearms, hunting and related products, today announced it has entered into a definitive agreement to sell its ammunition manufacturing assets to Olin Winchester, LLC (“Olin Winchester”), a subsidiary of Olin Corporation (NYSE: OLN) (“Olin”), for total cash consideration of $75 million, subject to customary adjustments.

CLAYTON, Mo. , Jan. 7, 2025 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced today that on Friday, January 31, 2025, at 9:00 a.m.

Olin Corporation shares fell 38% in 2024 due to weak Chinese demand and management turnover, creating a potential value opportunity for 2025. Despite ongoing challenges, new management's guidance and cost-cutting plans aim to double EBITDA and return $1 billion annually to shareholders by 2029. The company's financial position allows for incremental growth, with strategic options for its North American PVC business unlikely to be particularly large.

Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CLAYTON, Mo. , Sept. 30, 2024 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced today that on Friday, October 25, 2024, at 9:00 a.m.